Decentralize data sharing
In the field of life sciences, research data is often monopolized in the hands of a few institutions, which makes it difficult to share scientific research results and even duplication of efforts is frequent.AiB is committed to breaking this bottleneck and creating a global life sciences data sharing platform through decentralized technology:
Data on Chain: Key life science data such as experimental data, genome sequences, clinical trial results, etc. can be encrypted, stored and shared on the blockchain to ensure data security and traceability.
Open access: Researchers can quickly access global scientific data on the platform, while data contributors can be rewarded for data usage through NFTization.
Cross-disciplinary collaboration: AI-driven collaboration tools are built into the platform to help interdisciplinary teams communicate efficiently and break down barriers between fields.
Cross-disciplinary collaboration: AI-driven collaboration tools are built into the platform to help interdisciplinary teams communicate efficiently and break down barriers between fields.
Application Case:
Scientist A uploads a set of experimental data to the platform, the platform automatically generates NFTs for the data, other scientists can unlock the right to use the data by pledging $AiB, and the ownership and revenue of the data belongs to Scientist A.
A biotech company can buy the data on the chain for drug development on the platform and pay the data contributors directly, eliminating intermediary costs.
Last updated